A detailed history of Avantax Advisory Services, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 60,933 shares of VTRS stock, worth $697,073. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60,933
Previous 42,419 43.65%
Holding current value
$697,073
Previous $506,000 27.87%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$10.05 - $12.02 $186,065 - $222,538
18,514 Added 43.65%
60,933 $647,000
Q1 2024

May 08, 2024

SELL
$11.27 - $13.53 $8,599 - $10,323
-763 Reduced 1.77%
42,419 $506,000
Q4 2023

Feb 07, 2024

BUY
$8.77 - $10.85 $2,911 - $3,602
332 Added 0.77%
43,182 $467,000
Q3 2023

Nov 07, 2023

SELL
$9.59 - $11.35 $1,064 - $1,259
-111 Reduced 0.26%
42,850 $422,000
Q2 2023

Aug 11, 2023

BUY
$9.02 - $10.29 $3,869 - $4,414
429 Added 1.01%
42,961 $428,000
Q1 2023

Apr 28, 2023

BUY
$9.2 - $12.26 $5,777 - $7,699
628 Added 1.5%
42,532 $409,000
Q4 2022

Feb 13, 2023

SELL
$8.72 - $11.56 $37,216 - $49,338
-4,268 Reduced 9.24%
41,904 $466,000
Q3 2022

Nov 01, 2022

SELL
$8.48 - $11.13 $568 - $745
-67 Reduced 0.14%
46,172 $393,000
Q2 2022

Aug 02, 2022

SELL
$9.95 - $12.27 $13,412 - $16,539
-1,348 Reduced 2.83%
46,239 $484,000
Q1 2022

Apr 27, 2022

BUY
$9.81 - $15.4 $34,070 - $53,484
3,473 Added 7.87%
47,587 $481,000
Q4 2021

Jan 24, 2022

BUY
$12.09 - $14.68 $42,290 - $51,350
3,498 Added 8.61%
44,114 $597,000
Q3 2021

Oct 21, 2021

BUY
$13.25 - $15.13 $244,595 - $279,299
18,460 Added 83.32%
40,616 $531,000
Q2 2021

Jul 29, 2021

BUY
$12.97 - $16.15 $29,325 - $36,515
2,261 Added 11.36%
22,156 $290,000
Q1 2021

May 13, 2021

SELL
$13.59 - $18.54 $46,871 - $63,944
-3,449 Reduced 14.77%
19,895 $242,000
Q4 2020

Jan 22, 2021

BUY
$14.3 - $18.74 $333,819 - $437,466
23,344 New
23,344 $405,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13.9B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Avantax Advisory Services, Inc. Portfolio

Follow Avantax Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.